141 related articles for article (PubMed ID: 20008917)
21. Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study.
Lewden B; Vial T; Elefant E; Nelva A; Carlier P; Descotes J;
J Rheumatol; 2004 Dec; 31(12):2360-5. PubMed ID: 15570635
[TBL] [Abstract][Full Text] [Related]
22. [Smoking cessation and pregnancy].
Møller AM; Tønnesen H
Ugeskr Laeger; 1999 Sep; 161(36):4985-6. PubMed ID: 10489788
[TBL] [Abstract][Full Text] [Related]
23. Tumour necrosis factor inhibitors: risks and benefits in patients with rheumatoid arthritis.
Roberts L; McColl GJ
Intern Med J; 2004 Dec; 34(12):687-93. PubMed ID: 15610214
[TBL] [Abstract][Full Text] [Related]
24. Safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection.
Ferri C; Ferraccioli G; Ferrari D; Galeazzi M; Lapadula G; Montecucco C; Triolo G; Valentini G; Valesini G;
J Rheumatol; 2008 Oct; 35(10):1944-9. PubMed ID: 18688917
[TBL] [Abstract][Full Text] [Related]
25. Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12.
van Oosterhout M; Levarht EW; Sont JK; Huizinga TW; Toes RE; van Laar JM
Ann Rheum Dis; 2005 Apr; 64(4):537-43. PubMed ID: 15769913
[TBL] [Abstract][Full Text] [Related]
26. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
27. Infliximab treatment of rheumatoid arthritis and Crohn's disease.
Nahar IK; Shojania K; Marra CA; Alamgir AH; Anis AH
Ann Pharmacother; 2003 Sep; 37(9):1256-65. PubMed ID: 12921510
[TBL] [Abstract][Full Text] [Related]
28. Biologic therapies and pregnancy: the story so far.
Hyrich KL; Verstappen SM
Rheumatology (Oxford); 2014 Aug; 53(8):1377-85. PubMed ID: 24352337
[TBL] [Abstract][Full Text] [Related]
29. Anti-TNF therapy and pregnancy outcomes in women with inflammatory arthritis.
Vinet E; Pineau C; Gordon C; Clarke AE; Bernatsky S
Expert Rev Clin Immunol; 2009 Jan; 5(1):27-34. PubMed ID: 20476897
[TBL] [Abstract][Full Text] [Related]
30. Emerging data on the use of anti-tumor necrosis factor-alpha medications in pregnancy.
Chambers CD; Johnson DL
Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):607-11. PubMed ID: 22786755
[TBL] [Abstract][Full Text] [Related]
31. [Management of rheumatoid arthritis medications and pregnancy].
Funakubo Asanuma Y
Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):45-56. PubMed ID: 25765688
[TBL] [Abstract][Full Text] [Related]
32. Imaging of pregnant and lactating patients: part 1, evidence-based review and recommendations.
Wang PI; Chong ST; Kielar AZ; Kelly AM; Knoepp UD; Mazza MB; Goodsitt MM
AJR Am J Roentgenol; 2012 Apr; 198(4):778-84. PubMed ID: 22451541
[TBL] [Abstract][Full Text] [Related]
33. A survey of inclusion of the time element when reporting adverse effects in randomised controlled trials of cyclo-oxygenase-2 and tumour necrosis factor alpha inhibitors.
Yazici Y; Yazici H
Ann Rheum Dis; 2007 Jan; 66(1):124-7. PubMed ID: 16831828
[TBL] [Abstract][Full Text] [Related]
34. Psoriasis in pregnancy: a review (II).
Ruiz V; Manubens E; Puig L
Actas Dermosifiliogr; 2014 Nov; 105(9):813-21. PubMed ID: 24314892
[TBL] [Abstract][Full Text] [Related]
35. Pregnancy outcome in women exposed to leflunomide before or during pregnancy.
Cassina M; Johnson DL; Robinson LK; Braddock SR; Xu R; Jimenez JL; Mirrasoul N; Salas E; Luo YJ; Jones KL; Chambers CD;
Arthritis Rheum; 2012 Jul; 64(7):2085-94. PubMed ID: 22307734
[TBL] [Abstract][Full Text] [Related]
36. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation.
Götestam Skorpen C; Hoeltzenbein M; Tincani A; Fischer-Betz R; Elefant E; Chambers C; da Silva J; Nelson-Piercy C; Cetin I; Costedoat-Chalumeau N; Dolhain R; Förger F; Khamashta M; Ruiz-Irastorza G; Zink A; Vencovsky J; Cutolo M; Caeyers N; Zumbühl C; Østensen M
Ann Rheum Dis; 2016 May; 75(5):795-810. PubMed ID: 26888948
[TBL] [Abstract][Full Text] [Related]
37. Safety of TNF-α inhibitors during IBD pregnancy: a systematic review.
Nielsen OH; Loftus EV; Jess T
BMC Med; 2013 Jul; 11():174. PubMed ID: 23902720
[TBL] [Abstract][Full Text] [Related]
38. [Biologics during pregnancy and breast--feeding].
Fischer-Betz RE; Schneider M
Z Rheumatol; 2010 Nov; 69(9):780-7. PubMed ID: 21063826
[TBL] [Abstract][Full Text] [Related]
39. Meta-Analysis of Pregnancy Outcomes after Exposure to TNF-α Inhibitors During Pregnancy for the Treatment of Arthritic Diseases.
Mirdamadi K; Salinas T; Vali R; Papadimitropoulos M; Piquette-Miller M
J Popul Ther Clin Pharmacol; 2018 Apr; 25(1):e53-e56. PubMed ID: 29949681
[TBL] [Abstract][Full Text] [Related]
40. Pregnancy outcome in women who were exposed to anti-tumor necrosis factor agents: results from a national population register.
Hyrich KL; Symmons DP; Watson KD; Silman AJ;
Arthritis Rheum; 2006 Aug; 54(8):2701-2. PubMed ID: 16871549
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
